FocusTuberculosis

For Whom the Bell Tolls: Isoniazid Preventive Therapy and Tuberculosis Drug Resistance

Science Translational Medicine  10 Apr 2013:
Vol. 5, Issue 180, pp. 180fs12
DOI: 10.1126/scitranslmed.3006094

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the “double use” of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).

View Full Text